<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
YMAB
Y-mAbs Therapeutics
$
()


  • Y-mAbs Therapeutics CFO Bo Kruse resigns

    3/14/2024 - 09:07am
  • Y-mAbs Therapeutics price target raised by $1 at H.C. Wainwright, here's why

    3/6/2024 - 06:13am
  • Biotech Alert: Searches spiking for these stocks today

    3/4/2024 - 10:50am
  • Y-mAbs Therapeutics price target raised by $10 at BMO Capital, here's why

    3/4/2024 - 08:43am
  • Y-mAbs Therapeutics appoints Tagliaferri to board of directors

    3/4/2024 - 07:36am
  • Y-mAbs Therapeutics price target raised by $4 at Canaccord, here's why

    3/4/2024 - 07:32am
  • Y-mAbs Therapeutics sees FY24 revenue $95M-$100M, consensus $96.27M

    2/29/2024 - 16:23pm
  • Y-mAbs Therapeutics reports Q4 EPS (2c), consensus (20c)

    2/29/2024 - 16:22pm
  • Y-mAbs Therapeutics price target raised by $10 at H.C. Wainwright, here's why

    2/20/2024 - 06:16am
  • Biotech Alert: Searches spiking for these stocks today

    1/31/2024 - 10:56am
  • Fly Intel: After-Hours Movers

    12/13/2023 - 18:33pm
  • Y-mAbs Therapeutics sees FY23 DANYELZA revenue $80M- $85M, consensus $83.67M

    11/13/2023 - 16:29pm
  • Y-mAbs Therapeutics reports Q3 EPS (18c), consensus (19c)

    11/13/2023 - 16:26pm
  • Y-mAbs Therapeutics appoints Michael Rossi as CEO

    10/18/2023 - 16:11pm
  • Y-mAbs Therapeutics announces FDA clearance of CD38-SADA IND application

    10/17/2023 - 16:07pm
dynamic_feed Breaking News